Advertisement
Supplier News
Subscribe to Supplier News

The Lead

Phase 2a Begins for Genocea's Pneumococcus Vaccine

September 12, 2014 7:00 am | News | Comments

Genocea Biosciences, Inc. announced the initiation of a Phase 2a trial for GEN-004, the company’s universal vaccine candidate against pneumococcus. The trial is designed to evaluate the effect of dosing with GEN-004 on the frequency, magnitude and duration of colonization by pneumococcus in the nasopharynx of healthy adults.

Biogen Shows Positive Effects in Year Two of RMS Drug Trial

September 12, 2014 7:00 am | News | Comments

Biogen Idec announced new data from the second year of its Phase 3 ADVANCE clinical trial...

Data Validate 3x/Week MS Injections

September 12, 2014 7:00 am | News | Comments

Teva Pharmaceutical Industries Ltd. announced new...

How Outsourcing Can Accelerate the Drug Development Process

September 4, 2014 10:36 am | by Matthew Weinberg, CEO, The Weinberg Group | Articles | Comments

Outsourcing is an old concept in the healthcare industry that has recently been applied to a new...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Isis Initiates Phase 3 Study of FCS Drug

August 29, 2014 2:00 pm | News | Comments

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide. Read more...

Accelerate Drug Development with Optimized Content Management

August 29, 2014 8:30 am | by Steve Scribner, Principal Consultant – Life Sciences, EMC Information Intelligence Group | Articles | Comments

Getting a new drug from the laboratory to the pharmacy takes years of testing, applications and information sharing. One way to shorten the drug development life cycle is to optimize content management. Read more...          

Synthetic Biologics Improves Enzyme for C.diff Prevention

August 29, 2014 8:30 am | News | Comments

Synthetic Biologics, Inc. and FUJIFILM Diosynth Biotechnologies UK Limited have announced confirmation of exceptional results from the initial phase of cGMP manufacturing of SYN-004, Synthetic Biologics' proprietary oral beta-lactamase enzyme for the prevention of Clostridium difficile (C. difficile) infections. Read more...

Advertisement

The Future of Genome Analysis

August 28, 2014 9:30 am | by Maxim Mikheev, M.D., Ph.D., Co-Founder and Chief Technical Officer at BioDatomics | Articles | Comments

As technological improvements have changed the way we study the genome, the amount of data associated with a single DNA sample has increased exponentially. Surprisingly, throughout this evolution the hardware and software infrastructure supporting bioanalytics has barely changed. Read more...

TTP Labtech Technology IDs Novel Drug Candidates for Neuropsychiatric Disorders

July 25, 2014 2:50 pm | News | Comments

The first high-resolution X-ray crystal structure of the metabotropic glutamate receptor 5 transmembrane domain was reported in Nature this week. The work was performed at Heptares Therapeutics using TTP Labtech’s innovative liquid handling technology for lipidic cubic phase crystallography. Read more...

Horizon Licenses CRISPR Gene Editing Technology from Broad Institute

June 13, 2014 11:22 am | News | Comments

Horizon Discovery Group plc announced it has entered into a non-exclusive license agreement with the Broad Institute to access intellectual property related to the CRISPR/Cas9 gene editing system.  Read more...          

Horizon Discovery Acquires New Assets

May 23, 2014 1:39 pm | News | Comments

Horizon Discovery Group plc, the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, announced it has agreed to acquire the CombinatoRx service business and related assets from Zalicus Inc., for £4.74m ($8.0m USD). Read more...

AMSBIO Expands U.S. Operations

April 23, 2014 12:58 pm | News | Comments

AMSBIO has announced the opening of a new North American headquarters with executive management facilities in Cambridge, Mass., for its U.S. subsidiary, AMSBIO LLC, recognized  as a leading company contributing to the acceleration of discovery. Read more...

Advertisement

Breaking News: Cubist Recalls Cubicin Lot

April 18, 2014 2:02 pm | News | Comments

Cubist Pharmaceuticals Inc. announced it is voluntarily recalling one lot of Cubicin (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles. Read more...

Breaking News: EMA Warns of Falsified Herceptin

April 16, 2014 9:09 am | News | Comments

The EMA has been informed that vials of the cancer medicine Herceptin, thought to have been stolen in Italy, including from hospitals, have been tampered with and re-introduced under false credentials into the supply chain in some countries. Read more...

Traceable Tissue Storage Solution

April 2, 2014 4:18 pm | Product Releases | Comments

Micronic has launched a new externally threaded 3.00 ml tube that provides a fully traceable storage solution for tissue samples. Read more...

GE Healthcare Names 2013 Imaging Competition Winners

March 12, 2014 10:47 am | News | Comments

GE Healthcare Life Sciences announced Vanessa Auld, from Canada, Martin Barr, from Ireland, and Graham Wright, from Singapore, as the winners of the GE Healthcare 2013 Cell Imaging Competition. Read more...             

GE Healthcare Invests in FISH Technologies for Leukemia and Lymphoma Testing

March 5, 2014 9:50 am | News | Comments

GE Healthcare announced that Clarient Diagnostic Service, Inc., a GE Healthcare company, has made significant upgrades to its fluorescence in situ hybridization (FISH) technologies to improve virtual analysis of testing results for a variety of blood diseases, including leukemia, lymphoma, myelodysplastic syndrome, and myeloma.

Advertisement

Regulator OKs Thermo Fisher $13.6B Life Tech Deal

February 4, 2014 8:58 am | News | Comments

The Federal Trade Commission said Friday it has approved Thermo Fisher Scientific Inc.'s $13.6 billion acquisition of Life Technologies Corp., as long as the scientific instrument maker sells some assets to a unit of General Electric Co.    

Medivir AB to Use Certara’s Drug Discovery Platform

January 27, 2014 10:00 am | News | Comments

Certara announced that Medivir AB, a Swedish pharmaceutical company that focuses on infectious diseases including hepatitis C, has selected D360 as its global drug discovery platform. Read more...               

Organovo Announces Collaboration with NIH

January 14, 2014 2:04 pm | News | Comments

Organovo announced that they are joining together with two institutes from the National Institutes of Health (NIH) to help scientists develop more reliable tools for bringing safer, more effective treatments to patients on a faster timeline.    

TTP Labtech Acquires Assets in Fluorescence Lifetime Technology

January 9, 2014 10:16 am | News | Comments

Improvements in assay reagents and availability of high-throughput screen (HTS)-compatible readers has made fluorescence lifetime (FLT) technology a cost-effective screening technology. TTP Labtech has consolidated its position in the field with the purchase of assets from AssayMetrics Limited, a FLT company.

Thermo Fisher Scientific to Sell $1.06B in Assets to GE

January 6, 2014 10:49 am | News | Comments

Thermo Fisher Scientific announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company, for approximately $1.06 billion.    

Ready-to-Use Stable Cell Lines

January 2, 2014 10:48 am | Product Releases | Comments

AMSBIO has expanded its portfolio of stable cell lines. The new cell lines express endogenous or recombinant proteins and are available in a ready-to-use format to facilitate your research efforts. 

High-Temperature Cold/Hot Plates

December 26, 2013 9:54 am | Product Releases | Comments

Designed for laboratory research, TECA's high-temperature versions of several cold/hot plate models can heat up to +150 °C.

Evaporator for Drug Discovery

December 18, 2013 1:04 pm | Product Releases | Comments

The HT-4X centrifugal evaporator from Genevac provides sample preparation capabilities for scientists working in the drug discovery environment.

Horizon Discovery, Desktop Genetics Collaborate on CRISPR Platform

December 18, 2013 12:56 pm | News | Comments

Horizon Discovery has entered into a collaboration agreement with Desktop Genetics for development of a CRISPR design platform. The platform will be used by Horizon to quickly identify the best guide-RNAs in the human genome for each gene editing task, as part of its GENESIS suite of gene-editing technologies.

Semi-Automatic Microplate Sealer

December 12, 2013 2:01 pm | Product Releases | Comments

The MiniSeal II semi-automatic microplate sealer from Porvair Sciences comes complete with adapters enabling it to process deep-well, shallow-well, low-profile deep-well, filter and assay plates that conform to the ANSI/SLAS standard format. Learn more...

ImmunoChemistry Technologies Changes Ownership

December 6, 2013 11:27 am | News | Comments

ImmunoChemistry Technologies (ICT), a Minnesota-based biotechnology company that supplies unique biochemical laboratory reagents and assay tests to medical researchers, has changed ownership. Now majority women-owned, ICT develops new products to help researchers discover new treatments and drugs for cancer and other diseases affecting both animals and humans.

LiverChip Platform Tested

December 3, 2013 4:31 pm | News | Comments

Zyoxel has announced preliminary results from a testing by Sanofi on Zyoxel’s  LiverChip platform for drug metabolism and pharmacokinetic (DMPK) studies. So for what applications was the platform especially useful in the testing? Find out...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading